Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
10.36
-0.24 (-2.26%)
At close: Dec 5, 2025, 4:00 PM EST
10.56
+0.20 (1.93%)
After-hours: Dec 5, 2025, 7:17 PM EST
Verastem Employees
Verastem had 78 employees as of December 31, 2024. The number of employees increased by 5 or 6.85% compared to the previous year.
Employees
78
Change (1Y)
5
Growth (1Y)
6.85%
Revenue / Employee
$171,526
Profits / Employee
-$3,091,103
Market Cap
799.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VSTM News
- 10 days ago - Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference - Business Wire
- 22 days ago - Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 22 days ago - Verastem Oncology Announces Proposed Public Offering of Common Stock - Business Wire
- 4 weeks ago - Verastem Oncology to Present at Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - Business Wire
- 6 weeks ago - Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors - Business Wire
- 6 weeks ago - Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025 - Business Wire